Last $6.10 USD
Change Today -0.10 / -1.61%
Volume 3.1M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward M. Fitzgerald

Chief Financial Officer, Executive Vice President and Treasurer, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59$2,026,534
As of Fiscal Year 2013

Background*

Mr. Edward M. Fitzgerald has been the Chief Financial Officer and Treasurer of ARIAD Pharmaceuticals, Inc. since May 2002 and has been its Executive Vice President since June 2010. Mr. Fitzgerald served as Senior Vice President of Finance & Corporate Operations and Principal Accounting Officer at Ariad Pharmaceuticals Inc. From 1998 to April 2002, he served as Senior Vice President, Chief Financial Officer and Secretary of Twin Butte Energy Ltd. (formerly AltaRex Corp.), ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Babson College
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$465,354
Total Annual Compensation$465,354

Stock Options*

Restricted Stock Awards$678,925
All Other Compensation$30,306
Exercised Options33,000
Exercised Options Value$468,930
Exercisable Options322,333
Exercisable Options Value$419,600
Unexercisable Options131,667
Unexercisable Options Value$35,700
Total Value of Options$924,230
Total Number of Options487,000

Total Compensation*

Total Annual Cash Compensation$495,660
Total Short Term Compensation$465,354
Other Long Term Compensation$709,231
Total Calculated Compensation$2,026,534
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $6.10 USD -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€601.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.